Browse CATs

Browse CATs  internal medicine  haematology  anticoagulation

Economics Prognosis Therapy Bleeding Heparin LMWH Warfarin

Acute myocardial infarction Heparin is of equivocal benefit with aspirin and thrombolysis Level of evidence 1a Expiry Date January 2002 Anticoagulation weight-adjusted heparin dosing was effective. Level of evidence 1b Expiry Date June 2002 Anticoagulation weight-based algorithm for subcutaneous heparin was useful. Level of evidence 4 Expiry Date June 2002 Anticoagulation (long term) subcutaneous heparin reduced bleeds. Level of evidence 1b Expiry Date June 2002 Anticoagulation and DVT subcutaneous heparin leads to fewer recurrences than continuous intravenous heparin. Level of evidence 1a Expiry Date June 2002 Deep vein thrombosis heparin and warfarin is more effective than warfarin alone. Level of evidence 1b Expiry Date May 2001 Deep vein thrombosis danaparoid was not clearly better than heparin. Level of evidence 1b- Expiry Date May 2001 Heparin heparin-resistant patients: anti-factor Xa may no better than aPTT for monitoring dosing. Level of evidence 1b- Expiry Date June 2002 Pregnancy and heparin low-risk of vertebral fractures and bleeds Level of evidence 4 Expiry Date June 2002 Pregnancy and heparin prolonged use led to a small reduction in femur bone density. Level of evidence 4 Expiry Date June 2002 Unstable angina heparin and aspirin may be better than aspirin alone. Level of evidence 1a- Expiry Date July 2002